BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26561290)

  • 1. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
    Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
    Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare genetic variants support mitochondrial dysfunction in Lewy body disorders.
    Wider C; Mouradian MM
    Neurology; 2015 Dec; 85(23):2002-3. PubMed ID: 26561295
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic analysis of CHCHD2 in a southern Spanish population.
    Tejera-Parrado C; Jesús S; Huertas-Fernández I; Bernal-Bernal I; Bonilla-Toribio M; Córdoba-Tevar I; Abreu-Rodríguez I; Carrillo F; Bernal-Escudero M; Vargas-González L; Carballo M; Gómez-Garre P; Mir P
    Neurobiol Aging; 2017 Feb; 50():169.e1-169.e2. PubMed ID: 27839904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
    Rubino E; Brusa L; Zhang M; Boschi S; Govone F; Vacca A; Gai A; Pinessi L; Lopiano L; Rogaeva E; Rainero I
    Neurobiol Aging; 2017 May; 53():193.e7-193.e8. PubMed ID: 28108040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.
    Zheng K; Heydari B; Simon DK
    Arch Neurol; 2003 May; 60(5):722-5. PubMed ID: 12756136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
    Labbé C; Ogaki K; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Rayaprolu S; Fujioka S; Murray ME; Heckman MG; Puschmann A; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Sanotsky Y; Rektorová I; McLean PJ; Rademakers R; Ertekin-Taner N; Hassan A; Ahlskog JE; Boeve BF; Petersen RC; Maraganore DM; Adler CH; Ferman TJ; Parisi JE; Graff-Radford NR; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
    Neurology; 2015 Nov; 85(19):1680-6. PubMed ID: 26333800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.
    Zhang M; Xi Z; Fang S; Ghani M; Sato C; Moreno D; Liang Y; Lang AE; Rogaeva E
    Neurobiol Aging; 2016 Feb; 38():217.e7-217.e8. PubMed ID: 26639156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHCHD2 mutational screening in Brazilian patients with familial Parkinson's disease.
    Voigt DD; Nascimento CM; de Souza RB; Cabello Acero PH; Campos Júnior M; da Silva CP; Pereira JS; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Della Coletta MV; da Silva DJ; Nicaretta DH; Gonçalves AP; Dos Santos JM; Calassara V; Santos-Rebouças CB; Pimentel MMG
    Neurobiol Aging; 2019 Feb; 74():236.e7-236.e8. PubMed ID: 30342766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD2 gene mutations in familial and sporadic Parkinson's disease.
    Shi CH; Mao CY; Zhang SY; Yang J; Song B; Wu P; Zuo CT; Liu YT; Ji Y; Yang ZH; Wu J; Zhuang ZP; Xu YM
    Neurobiol Aging; 2016 Feb; 38():217.e9-217.e13. PubMed ID: 26705026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the CHCHD2 gene in Chinese patients with familial essential tremor.
    Wu H; Lu X; Cen Z; Xie F; Zheng X; Chen Y; Luo W
    Neurosci Lett; 2016 Nov; 634():104-106. PubMed ID: 27717833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
    Li NN; Wang L; Tan EK; Cheng L; Sun XY; Lu ZJ; Li JY; Zhang JH; Peng R
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1148-1152. PubMed ID: 27626775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease.
    Wu H; Lu X; Xie F; Cen Z; Zheng X; Luo W
    Neurosci Lett; 2016 Aug; 629():116-118. PubMed ID: 27353515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational scanning of the CHCHD2 gene in Han Chinese patients with Parkinson's disease and meta-analysis of the literature.
    Yang X; Zhao Q; An R; Zheng J; Tian S; Chen Y; Xu Y
    Parkinsonism Relat Disord; 2016 Aug; 29():42-6. PubMed ID: 27269965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
    Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
    Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
    Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
    Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
    Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.
    Lorenzo-Betancor O; Ogaki K; Soto-Ortolaza AI; Labbe C; Walton RL; Strongosky AJ; van Gerpen JA; Uitti RJ; McLean PJ; Springer W; Siuda J; Opala G; Krygowska-Wajs A; Barcikowska M; Czyzewski K; McCarthy A; Lynch T; Puschmann A; Rektorova I; Sanotsky Y; Vilariño-Güell C; Farrer MJ; Ferman TJ; Boeve BF; Petersen RC; Parisi JE; Graff-Radford NR; Dickson DW; Wszolek ZK; Ross OA
    Eur J Neurol; 2015 Sep; 22(9):1323-5. PubMed ID: 26278106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.
    Fan TS; Lin HI; Lin CH; Wu RM
    Neurobiol Aging; 2016 Feb; 38():218.e1-218.e2. PubMed ID: 26725463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
    Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
    Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.